This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Leslie C. Grammer, MD
Northwestern University Medical School Chicago, Ill

JAMA. 1996;276(12):950.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Reynolds is certainly correct that cefaclor is the most common cause of serum sickness and is more commonly implicated than any other β-lactam drug. However, as I stated in my initial opinion, at present there are no large series of patients reported who have had serum sickness to cefaclor and subsequently tolerated administration or another β-lactam, nor has the mechanism been reported to be attributable to contaminants unique to cefaclor.

The case report that Reynolds describes in his letter is quite interesting. Accompanied by the other 9 cases that he and his partners have seen, this would probably be publishable and would begin to fill the void of published large series of patients who have had cefaclor serum sickness and then tolerated other β-lactam drugs. Until there are literature reports of large series of such patients or of unique contaminants as the cause of cefaclor serum sickness, it seems . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?